Understanding neurocysticercosis outcomes in treated patients
Part of Brain & nervous system, Infections clinical trials.
This study follows patients who have been treated for neurocysticercosis—a brain infection caused by a parasite—to learn how they recover over time and what long-term effects they experience. By joining, you'll help doctors better understand this condition and improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 3 years or older (or 18+ if you're in the exposure-history group)
- Ability to understand the study and sign consent (parent or guardian can sign for children)
- Confirmed or likely diagnosis of neurocysticercosis, OR a history suggesting possible exposure to the parasite
- Already received treatment for neurocysticercosis (for the main study groups)
- Willingness to participate in long-term follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving two medicines (praziquantel and albendazole) together works better than just one medicine (albendazole) to kill the parasite that causes neurocysticercosis. If you have this brain infection and have had seizures, you might be able to participate.
This study tests whether watching a medical TV drama on Netflix can help young adults learn more about neurocysticercosis, a brain infection caused by a tapeworm. If you are between 18 and 35 and enjoy watching shows, you might help researchers understand how entertainment can improve health knowledge.
This study looks at how infections or inflammation involving the brain and spinal cord work, using patient data and samples. It may help researchers better understand these illnesses and improve future care.
This is a research program at the National Institutes of Health that evaluates and treats people with surgical brain and nerve conditions—like brain tumors, epilepsy, Parkinson's disease, and chronic pain. You'll receive expert evaluation and care while helping doctors learn more about these disorders.
This study looks for and tracks nervous system problems in people with immune system disorders. It aims to better understand how infections or inflammation affect the brain and nerves in these patients.
This study follows people with neurofibromatosis type 2 (NF2) over time to learn how the condition changes, using repeat MRI scans. The information may help researchers understand disease patterns and improve future treatments.
Hear when a new Neurocysticercosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.